PRIMARY IMMUNODEFICIENCY IN CHILDREN IN TUZLA COUNTY

Authors

  • Belkisa Colic-Hadzic University Clinical Center Tuzla, Clinic for paediatric diseases
  • Nada Mladina University Clinical Center Tuzla, Clinic for paediatric diseases
  • Devleta Hadzic University Clinical Center Tuzla, Clinic for paediatric diseases
  • Elvira Konjic University Clinical Center Tuzla, Clinic for paediatric diseases

DOI:

https://doi.org/10.5457/ams.v37i2.8

Keywords:

primary immunodeficiency, early detection, children

Abstract

Introduction: The aim of the present study was to indicate importance of early detection of primary immunodeficiency in children, to determine the type of disorders and apply profilaxis and therapy. Material and Methods: The study was retrospective- prospective, during the period from 01.01.1997 to 31.12.2007 at Pediatric clinik, University Clinical Centre Tuzla. Results and Discussion: There were 53 patients both genders, age 1 month to 12.7 years (average age 3.0±3.4). In 33 (62.4%) patients diagnosis of primary immunodeficinecy was estimated until 3. years of life, cellular imunodeficinency disorders was diagnosed in 1 (1.9%), humoral 47 (88.8%) and C3 complement deficit in 5 (9.3%) of our patients. Since 2004 we registrated in crease new diagnosed, which point we started with screening among patients with repeated infections. Therapy and prophilaxy was administrated according usualy guidelines for these disorders of imunity. Therapy result was different according to type disorders, child age, and previous infections. After treatment, 37 (70%) patients recovered, as same as in 9 (17%), the worse condition in 2 (4%), and death in 5 (9%). Conclusion: According to accepted incidence in generall population presented number of immunodefitienti patients in our region is not adekvate and intensive detection in future period is neccessary.

Downloads

Issue

Vol. 37 No. 2 (2008)

Section

Original papers

License

Copyright transfer

The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.